Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Journal of Hepatology|July 30, 2016
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON studyJorge A Marrero, Masatoshi Kudo, Alan P Venook, et al.
Advances in Radiation Oncology|December 24, 2025
Radioenhancing Hafnium Oxide Nanoparticles (NBTXR3) Followed by Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma and Liver Metastases (NBTXR3-103): Phase 1 Dose-Escalation TrialEnrique Chajon, Marc Pracht, Yan Rolland, et al.
Antiviral Therapy|April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final resultsStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Journal of Clinical Medicine|December 8, 2019
Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV InfectionChristiana Graf, Antonia Mondorf, Viola Knop, et al.
The American Journal of Clinical Nutrition|March 9, 2006
Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populationsRosa-Maria Guéant-Rodriguez, Jean-Louis Guéant, Renée Debard, et al.
Journal of Hepatology|May 25, 2019
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinomaJean-Louis Jouve, Thierry Lecomte, Olivier Bouché, et al.
Gastroenterology|May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevirFred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2020
Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patientsThomas Mouillot, Maud Rizk, Jean-Paul Pais de Barros, et al.
Liver Cancer|December 15, 2025
Cabozantinib for Hepatocellular Carcinoma in Real-World Practice (CLERANCE): A Prospective, Interventional StudyFrançois Villeret, Mohamed Bouattour, Jean-Frédéric Blanc, et al.
Ebiomedicine|April 9, 2018
Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular CarcinomaAbderrahim Oussalah, Susann Rischer, Mouni Bensenane, et al.
Pageof 20